This application proposes to establish an adult AIDS Clinical Trials Unit in Philadelphia, combining resources from two major medical centers, the University of Pennsylvania and Thomas Jefferson University. 140 patients/year will be enrolled in clinical trials, 80 at the Hospital of the University of Pennsylvania (HUP) and 60 at Thomas Jefferson University Hospital (TJUH). These include 60-75 with primary HIV infection (enrollment at both centers), 40-60 with opportunistic infections (enrollment at both centers), 10 with HIV related malignancies (enrollment at HUP primarily), and 10 with neurologic complications of HIV disease (enrollment at HUP primarily). The addiction treatment clinic at Girard Medical Center will serve as a site for enrolling HIV infected intravenous drug users (IVDUs). The TJUH group follows a large population of pregnant women who are IVDUs, approximately 15% of whom are HIV infected. The large Hemophiliac Center at TJUH will be a major source of patients for study. Approximately 50% of HIV positive patients treated at our two centers are minorities, and 15-20% are women. We also propose to establish Core laboratories in virology at Penn and pharmacology at Jefferson. The virology lab will perform all protocol mandated viral studies, and in addition quantitative cultures, quantitative PCR, assays to detect HTLV-I or -II infection in IVDUs, and assays to monitor HSV, CMV, and VZV isolates for emergence of resistance to antivirals. The pharmacology lab will provide analytical and pharmacokinetic support for protocols of investigational agents. A developmental virology project is proposed for TJUH that evaluates a new technique, in situ PCR, for detection of HIV-1 genome within intact cells. In addition, quantitative RNA PCR will be used to evaluate changes in HIV transcription that occur in response to therapy. This application brings together experienced investigators and offers a large community of HIV infected patients an opportunity to participate in NIH sponsored clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01AI032783-01
Application #
3547987
Study Section
Special Emphasis Panel (SRC (35))
Project Start
1992-04-01
Project End
1996-01-31
Budget Start
1992-04-01
Budget End
1993-01-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Bisson, Gregory P; Ramchandani, Ritesh; Miyahara, Sachiko et al. (2017) Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults. AIDS 31:2217-2225
Tebas, Pablo; Roberts, Christine C; Muthumani, Kar et al. (2017) Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report. N Engl J Med :
Bar, Katharine J; Sneller, Michael C; Harrison, Linda J et al. (2016) Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption. N Engl J Med 375:2037-2050
Kempen, John H; Sugar, Elizabeth A; Varma, Rohit et al. (2014) Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections. Ophthalmology 121:2317-24
Kozak, Igor; Vaidya, Vijay; Van Natta, Mark L et al. (2014) The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis. Invest Ophthalmol Vis Sci 55:4304-12
Hulgan, Todd; Stein, James H; Cotter, Bruno R et al. (2013) Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation. AIDS Res Hum Retroviruses 29:1293-9
Jabs, Douglas A; Ahuja, Alka; Van Natta, Mark et al. (2013) Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 120:1262-70
Wohl, David A; Kendall, Michelle A; Feinberg, Judith et al. (2013) The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit. PLoS One 8:e78676
Huang, Jeannie S; Hughes, Michael D; Riddler, Sharon A et al. (2013) Bone mineral density effects of randomized regimen and nucleoside reverse transcriptase inhibitor selection from ACTG A5142. HIV Clin Trials 14:224-34
Gangaputra, Sapna; Drye, Lea; Vaidya, Vijay et al. (2013) Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 155:206-212.e5

Showing the most recent 10 out of 104 publications